Publication details

Efficacy and tolerance of dasatinib after imatinib failure or intolerance for patients with chronic myeloid leukemia treated in three different hospitals compare well with results achievable in formal clinical trials.

Authors

ŽÁČKOVÁ Daniela KLAMOVÁ Hana MUŽÍK Jan CMUNT Edmund RÁČIL Zdeněk MACHOVÁ POLÁKOVÁ Kateřina DVOŘÁKOVÁ Dana JURČEK Tomáš RÁZGA Filip CETKOVSKÝ Petr DUŠEK Ladislav MAYER Jiří

Year of publication 2013
Type Article in Periodical
Magazine / Source Leukemia & Lymphoma
MU Faculty or unit

Central European Institute of Technology

Citation
Web http://informahealthcare.com/doi/abs/10.3109/10428194.2013.772173
Doi http://dx.doi.org/10.3109/10428194.2013.772173
Field Oncology and hematology
Keywords chronic myeloid leukemia; formal clinical trials; dasatinib; imatinib
Attached files
Description Efficacy and tolerance of dasatinib after imatinib failure or intolerance for patients with chronic myeloid leukemia treated in three different hospitals compare well with results achievable in formal clinical trials. Efficacy and tolerance of dasatinib after imatinib failure or intolerance for patients with chronic myeloid leukemia treated in three different hospitals compare well with results achievable in formal clinical trials.

You are running an old browser version. We recommend updating your browser to its latest version.

More info